Changes in Body Compositions and Basal Metabolic Rates during Treatment of Graves’ Disease
Objectives. Because thyroid hormone is an important determinant of body weight and basal metabolic rate, we investigated the changes in the basal metabolic rate and body composition sequentially after treatment for Graves’ disease. Methods. A prospective cohort study was performed with six women new...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2018/9863050 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832550684369616896 |
|---|---|
| author | Min Joo Kim Sun Wook Cho Sumin Choi Dal Lae Ju Do Joon Park Young Joo Park |
| author_facet | Min Joo Kim Sun Wook Cho Sumin Choi Dal Lae Ju Do Joon Park Young Joo Park |
| author_sort | Min Joo Kim |
| collection | DOAJ |
| description | Objectives. Because thyroid hormone is an important determinant of body weight and basal metabolic rate, we investigated the changes in the basal metabolic rate and body composition sequentially after treatment for Graves’ disease. Methods. A prospective cohort study was performed with six women newly diagnosed with Graves’ disease. During a 52-week treatment of methimazole, body composition, resting respiratory expenditure (REE), and handgrip strength were measured consecutively. Results. After methimazole treatment, body weight was initially increased (0–8 weeks), subsequently plateaued (8–24 weeks), and gradually decreased in the later period (24–52 weeks) despite the decreased food intake. The measured REE was 40% higher than the predicted REE at baseline, and it gradually decreased after treatment. REE positively correlated with thyroid hormone levels, peripheral deiodinase activity, and thyroid’s secretory capacity. Body compositional analyses showed that the fat mass increased during an earlier period (4–12 weeks), while the lean mass increased significantly during the later period (26–52 weeks). Consistent with the lean mass changes, muscle strength also significantly increased during the later period. Conclusions. Treatment of Graves’ disease increased body weight and fat mass transiently with decreased REE. However, long-term compositional changes moved in a beneficial direction increasing lean mass and reinforcing muscle strength, following decreasing fat percentages. |
| format | Article |
| id | doaj-art-2e1fe1385e6c471f8c2aa8e758f47d35 |
| institution | Kabale University |
| issn | 1687-8337 1687-8345 |
| language | English |
| publishDate | 2018-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Endocrinology |
| spelling | doaj-art-2e1fe1385e6c471f8c2aa8e758f47d352025-02-03T06:06:07ZengWileyInternational Journal of Endocrinology1687-83371687-83452018-01-01201810.1155/2018/98630509863050Changes in Body Compositions and Basal Metabolic Rates during Treatment of Graves’ DiseaseMin Joo Kim0Sun Wook Cho1Sumin Choi2Dal Lae Ju3Do Joon Park4Young Joo Park5Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of KoreaDepartment of Internal Medicine, Seoul National University Hospital, Seoul, Republic of KoreaDepartment of Food Service and Nutrition Care, Seoul National University Hospital, Seoul, Republic of KoreaDepartment of Food Service and Nutrition Care, Seoul National University Hospital, Seoul, Republic of KoreaDepartment of Internal Medicine, Seoul National University Hospital, Seoul, Republic of KoreaDepartment of Internal Medicine, Seoul National University Hospital, Seoul, Republic of KoreaObjectives. Because thyroid hormone is an important determinant of body weight and basal metabolic rate, we investigated the changes in the basal metabolic rate and body composition sequentially after treatment for Graves’ disease. Methods. A prospective cohort study was performed with six women newly diagnosed with Graves’ disease. During a 52-week treatment of methimazole, body composition, resting respiratory expenditure (REE), and handgrip strength were measured consecutively. Results. After methimazole treatment, body weight was initially increased (0–8 weeks), subsequently plateaued (8–24 weeks), and gradually decreased in the later period (24–52 weeks) despite the decreased food intake. The measured REE was 40% higher than the predicted REE at baseline, and it gradually decreased after treatment. REE positively correlated with thyroid hormone levels, peripheral deiodinase activity, and thyroid’s secretory capacity. Body compositional analyses showed that the fat mass increased during an earlier period (4–12 weeks), while the lean mass increased significantly during the later period (26–52 weeks). Consistent with the lean mass changes, muscle strength also significantly increased during the later period. Conclusions. Treatment of Graves’ disease increased body weight and fat mass transiently with decreased REE. However, long-term compositional changes moved in a beneficial direction increasing lean mass and reinforcing muscle strength, following decreasing fat percentages.http://dx.doi.org/10.1155/2018/9863050 |
| spellingShingle | Min Joo Kim Sun Wook Cho Sumin Choi Dal Lae Ju Do Joon Park Young Joo Park Changes in Body Compositions and Basal Metabolic Rates during Treatment of Graves’ Disease International Journal of Endocrinology |
| title | Changes in Body Compositions and Basal Metabolic Rates during Treatment of Graves’ Disease |
| title_full | Changes in Body Compositions and Basal Metabolic Rates during Treatment of Graves’ Disease |
| title_fullStr | Changes in Body Compositions and Basal Metabolic Rates during Treatment of Graves’ Disease |
| title_full_unstemmed | Changes in Body Compositions and Basal Metabolic Rates during Treatment of Graves’ Disease |
| title_short | Changes in Body Compositions and Basal Metabolic Rates during Treatment of Graves’ Disease |
| title_sort | changes in body compositions and basal metabolic rates during treatment of graves disease |
| url | http://dx.doi.org/10.1155/2018/9863050 |
| work_keys_str_mv | AT minjookim changesinbodycompositionsandbasalmetabolicratesduringtreatmentofgravesdisease AT sunwookcho changesinbodycompositionsandbasalmetabolicratesduringtreatmentofgravesdisease AT suminchoi changesinbodycompositionsandbasalmetabolicratesduringtreatmentofgravesdisease AT dallaeju changesinbodycompositionsandbasalmetabolicratesduringtreatmentofgravesdisease AT dojoonpark changesinbodycompositionsandbasalmetabolicratesduringtreatmentofgravesdisease AT youngjoopark changesinbodycompositionsandbasalmetabolicratesduringtreatmentofgravesdisease |